glutamine and Ovarian Neoplasms

glutamine has been researched along with Ovarian Neoplasms in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.78)	18.2507
2000's	5 (13.89)	29.6817
2010's	18 (50.00)	24.3611
2020's	12 (33.33)	2.80

Authors

Authors	Studies
Fang, CY; Lei, MZ; Lei, QY; Li, JT; Li, KY; Lu, HJ; Pei, X; Qu, J; Shen, Y; Wen, W; Yang, HJ; Yin, M	1
Bae, S; Hong, J; Jang, SK; Jin, HO; Kim, G; Kim, YJ; Lee, JH; Park, IC	1
Baker, R; Bazzaro, M; Clemente, V; Erickson, BK; Hoshino, A; Khalifa, M; Lou, E; Nelson, A; Rubin, N; Shetty, M; Weroha, SJ	1
Ma, H; Qu, S; Yang, X; Zhai, Y	1
Datta, KK; Gowda, H; He, Y; Hooper, JD; Kalimutho, M; Khanna, KK; Lu, X; Maheshwari, UR; Mayoh, C; Raninga, PV; Venkat, P	1
Cai, X; Chen, G; Cui, C; He, L; Mai, Z; Shi, S; Tan, J; Tian, Y; Wang, X; Yang, Y; Yu, Z; Zhong, M	1
Antsaklis, P; Chionis, A; Daskalakis, G; Fasoulakis, Z; Katrachouras, A; Konis, K; Kontomanolis, EN; Koutras, A; Nikolettos, K; Ntounis, T; Pagkalos, A; Palios, VC; Perros, P; Prokopakis, I; Samara, AA; Sapantzoglou, I; Sotiriou, S; Symeonidis, P; Theodora, M; Valsamaki, A	1
Li, Y; Wang, J; Wang, L	1
Asaka, R; Asaka, S; Attarwala, N; Chen, X; Chen, YW; Chuang, CM; Davidson, B; DeMarzo, AM; Gaillard, S; Hong, J; Hsu, FC; Jung, JG; Le, A; Shen, YA; Shih, IM; Suryo Rahmanto, Y; Tomaszewski, A; Wang, TL; Yen, TT; Zhang, C	1
Guo, J; Mori, M; Satoh, K; Soga, T; Tabata, S; Tomita, M	1
Liu, L; Wang, X; Yang, T; Zhang, F; Zhao, J; Zhao, X	1
Abdulfatah, E; Ali-Fehmi, R; Alvero, AB; Buekers, T; Dar, S; Giri, S; Jiang, J; Li, J; Morris, R; Munkarah, A; Rattan, R; Sakr, S; Tang, A; Udumula, MP	1
Almeida, GS; Box, C; Chung, YL; deSouza, NM; Papaevangelou, E	1
Aoki, D; Furusawa, A; Inazawa, J; Inoue, J; Miyamoto, M; Miyasaka, N; Song, YS; Takano, M; Tsuda, H	1
LaFontaine, P; Masamha, CP	1
Astesana, V; Castedo, M; Chery, A; Durand, S; Joseph, A; Kroemer, G; Levesque, S; Michels, J; Obrist, F; Pietrocola, F; Pol, J; Wu, GS	1
Bettigole, SE; Cerliani, JP; Chae, CS; Chaurio, RA; Chopra, S; Conejo-Garcia, JR; Crowley, MJP; Cubillos-Ruiz, JR; Glimcher, LH; Holcomb, K; Konrad, C; Kossenkov, AV; Manfredi, G; Motorykin, I; Payne, KK; Rabinovich, GA; Raundhal, M; Rodriguez, PC; Rutkowski, MR; Sandoval, TA; Shin, HR; Song, M; Tan, C; Zamarin, D; Zhang, S	1
Dyer, A; Freedman, J; Frost, S; Jacobus, EJ; Jakeman, P; Schoeps, B; Scott, EM; Seymour, LW	1
Jiang, Y; Li, H; Li, J; Li, X; Pei, M; Wu, L	1
Achreja, A; Armaiz-Pena, G; Jiang, D; Liu, J; Lopez-Berestein, G; Mangala, LS; Marini, J; Mercado-Uribe, I; Moss, T; Nagrath, D; Ram, PT; Rodriguez-Aguayo, C; Roopaimoole, R; Sood, AK; Tsukamoto, T; Wahlig, S; Win, J; Yang, L; Zhao, H	1
Bae-Jump, VL; Guo, H; Jones, HM; Roque, DR; Sheng, X; Stine, JE; Willson, AK; Yuan, L; Zhou, C	1
Caparrotta, L; Catanzaro, D; Frezza, C; Gaude, E; Giordano, C; Guzzo, G; Montopoli, M; Orso, G; Ragazzi, E; Rasola, A	1
Chen, G; Guo, E; Guo, L; Liu, Z; Lu, H; Shan, W; Wang, C; Xia, M; Xu, Y; Zhou, B	1
Baudy, AR; Daemen, A; Evangelista, M; Gao, M; Haley, B; Hatzivassiliou, G; Pusapati, RV; Sandoval, W; Settleman, J; Wilson, C	1
Avril, N; Avril, S; DiFeo, A; Hudson, CD; Joseph, P; Nagaraj, AB; Savadelis, A	1
Budczies, J	1
Bast, RC; Bhattacharya, PK; Engel, BJ; Gray, J; Kelderhouse, LE; Lu, Z; Mao, W; McCullough, CR; Millward, SW; Ornelas, A; Sutton, MN; Wang, Y; Yang, H; Zacharias, NM	1
Achreja, A; Baddour, J; Choi, HH; Han, C; Huang, C; Ji, G; Li, J; Li, Y; Liu, Y; Lu, X; Nagrath, D; Wan, G; Yang, L; Zhang, X	1
Adachi, K; Arimoto, T; Eguchi, S; Fujii, T; Fujikawa, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M	1
Adachi, K; Eguchi, S; Fujii, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M	1
Ghosh, S; Maity, P; Mallick, P; Roy, S	1
Brueggen, J; Friedlos, F; Marais, R; Matter, A; Maycroft, K; O'Reilly, T; Roussel, J; Spooner, RA; Springer, CJ; Stolz, B; Stribbling, SM; Wood, J	1
Banerjee, M; Ghosh, S; Maity, P; Roy, S	1
Forbes, A	1
Abdollahi, A; Godwin, AK; Hamilton, TC; Roberts, D; Schultz, DC; Sonoda, G; Testa, JR	1
Nagy, B; Papp, Z; Páy, A; Rigó, J; Tanyi, J	1

Reviews

3 review(s) available for glutamine and Ovarian Neoplasms

Article	Year
Ovarian Cancer and Glutamine Metabolism. International journal of molecular sciences, 2023, Mar-06, Volume: 24, Issue:5 Topics: Energy Metabolism; Female; Glutamine; Glycolysis; Humans; Neoplasms; Ovarian Neoplasms	2023
[Metabolome analysis of solid tumors]. Der Pathologe, 2016, Volume: 37, Issue:Suppl 2 Topics: 4-Aminobutyrate Transaminase; beta-Alanine; Biomarkers, Tumor; Breast; Breast Neoplasms; Colonic Neoplasms; Female; Gas Chromatography-Mass Spectrometry; Glutamic Acid; Glutaminase; Glutamine; Humans; Metabolome; Neoplasms; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Ovary	2016
Parenteral nutrition. Current opinion in gastroenterology, 2007, Volume: 23, Issue:2 Topics: Blood Glucose; Emulsions; Female; Glutamine; Growth Hormone; Humans; Hyperglycemia; Lipids; Male; Ovarian Neoplasms; Pancreatitis; Parenteral Nutrition; Sepsis	2007

Other Studies

33 other study(ies) available for glutamine and Ovarian Neoplasms

Article	Year
Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth. Science China. Life sciences, 2022, Volume: 65, Issue:10 Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cysteine; Female; Glutamine; Humans; Lipoylation; Malate Dehydrogenase; Ovarian Neoplasms; Respiration; Tricarboxylic Acids	2022
Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via mTORC1/S6K Signaling Pathway. International journal of molecular sciences, 2022, Aug-06, Volume: 23, Issue:15 Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Glutamine; Humans; Mechanistic Target of Rapamycin Complex 1; Ovarian Neoplasms; Paclitaxel; Ribosomal Protein S6 Kinases; Signal Transduction	2022
GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumors. Cancer research communications, 2022, Volume: 2, Issue:8 Topics: Adenocarcinoma, Clear Cell; Animals; DNA-Binding Proteins; Female; Glutaminase; Glutamine; Humans; Mice; Ovarian Neoplasms; Protective Factors; Transcription Factors	2022
circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis. Cellular & molecular biology letters, 2022, Oct-22, Volume: 27, Issue:1 Topics: Amino Acid Transport System ASC; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glutamine; Humans; MicroRNAs; Minor Histocompatibility Antigens; Ovarian Neoplasms; RNA, Circular; RNA, Messenger	2022
Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma. Molecular therapy : the journal of the American Society of Gene Therapy, 2023, 03-01, Volume: 31, Issue:3 Topics: Auranofin; Cell Line, Tumor; Female; Genes, myc; Glutaminase; Glutamine; Humans; Ovarian Neoplasms; Thioredoxin-Disulfide Reductase; Thioredoxins	2023
Glutamine metabolism targeting liposomes for synergistic chemosensitization and starvation therapy in ovarian cancer. Acta biomaterialia, 2023, 03-01, Volume: 158 Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Female; Glutamine; Glutathione; Humans; Lipopolysaccharides; Liposomes; Nucleotides; Ovarian Neoplasms; TOR Serine-Threonine Kinases	2023
Effect of glutamine on the immune function of paclitaxel intervention in ovarian cancer mice. Cellular and molecular biology (Noisy-le-Grand, France), 2020, May-16, Volume: 66, Issue:2 Topics: Animals; Cell Line, Tumor; Female; Glutamine; Humans; Mice, Inbred BALB C; Ovarian Neoplasms; Paclitaxel; T-Lymphocyte Subsets	2020
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers. Cancer research, 2020, 10-15, Volume: 80, Issue:20 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Glutathione; Humans; Mice, Nude; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins c-myc; Thiadiazoles; Xenograft Model Antitumor Assays	2020
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells. BMC cancer, 2021, Feb-17, Volume: 21, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cellular Reprogramming; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Silencing; Glutamate-Ammonia Ligase; Glutamine; Humans; Metabolome; Ovarian Neoplasms; Tumor Cells, Cultured	2021
Serum metabolite signatures of epithelial ovarian cancer based on targeted metabolomics. Clinica chimica acta; international journal of clinical chemistry, 2021, Volume: 518 Topics: Amino Acids; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Female; Glutamine; Humans; Metabolomics; Ovarian Neoplasms	2021
Ovarian cancer modulates the immunosuppressive function of CD11b Molecular metabolism, 2021, Volume: 53 Topics: Animals; Antigens, Ly; Carcinoma, Ovarian Epithelial; CD11b Antigen; Cell Line, Tumor; Female; Glutamine; Metabolomics; Mice; Mice, Congenic; Mice, Inbred C57BL; Myeloid Cells; Optical Imaging; Ovarian Neoplasms	2021
The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model. International journal of cancer, 2018, 08-15, Volume: 143, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Fatty Acid Synthase, Type I; Fatty Acids; Female; Glutamine; Humans; Mice; Orlistat; Ovarian Neoplasms; Oxidation-Reduction	2018
Ovarian cancer therapeutic potential of glutamine depletion based on GS expression. Carcinogenesis, 2018, 05-28, Volume: 39, Issue:6 Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Follow-Up Studies; Glutamate-Ammonia Ligase; Glutamine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Ovarian Neoplasms	2018
Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy. Journal of cellular biochemistry, 2018, Volume: 119, Issue:7 Topics: Antineoplastic Agents; Cell Proliferation; Drug Resistance, Neoplasm; Female; Glutaminase; Glutamine; Humans; Molecular Targeted Therapy; Ovarian Neoplasms; Sulfides; Thiadiazoles; Tumor Cells, Cultured	2018
Metabolic vulnerability of cisplatin-resistant cancers. The EMBO journal, 2018, 07-13, Volume: 37, Issue:14 Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Energy Metabolism; Female; Glutamine; Humans; Mass Spectrometry; Metabolome; Models, Biological; Nucleotides; Ovarian Neoplasms	2018
IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature, 2018, Volume: 562, Issue:7727 Topics: Amino Acid Transport Systems, Basic; Animals; Ascites; Cell Respiration; Disease Progression; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Glycosylation; Humans; Interferon-gamma; Mice; Mitochondria; Neoplasm Metastasis; Neoplasm Transplantation; Ovarian Neoplasms; Protein Serine-Threonine Kinases; Signal Transduction; Survival Rate; T-Lymphocytes; Tumor Escape; Unfolded Protein Response; X-Box Binding Protein 1	2018
Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells. Cancer research, 2019, 01-15, Volume: 79, Issue:2 Topics: A549 Cells; Adenoviridae; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Genome, Viral; Glutamine; Glycolysis; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Nude; Oncolytic Viruses; Ovarian Neoplasms; Oxidative Phosphorylation; Random Allocation; Virus Replication	2019
miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells. Cell biology international, 2019, Volume: 43, Issue:8 Topics: DNA-Binding Proteins; Female; Glutaminase; Glutamine; Humans; MicroRNAs; Ovarian Neoplasms; Transcription Factors; Tumor Cells, Cultured	2019
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Molecular systems biology, 2014, May-05, Volume: 10 Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Energy Metabolism; Female; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Ovarian Neoplasms; Prognosis; Signal Transduction	2014
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway. Endocrine-related cancer, 2015, Volume: 22, Issue:4 Topics: Adenosine Triphosphate; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Glucose; Glutamine; Humans; Lactic Acid; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Reactive Oxygen Species; Ribosomal Protein S6 Kinases; TOR Serine-Threonine Kinases	2015
Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death. Oncotarget, 2015, Oct-06, Volume: 6, Issue:30 Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; DNA, Mitochondrial; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Energy Metabolism; Enzyme Inhibitors; Female; Glucose; Glucosephosphate Dehydrogenase; Glutamine; Humans; Mitochondria; Ovarian Neoplasms; Signal Transduction; Time Factors	2015
Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Benzeneacetamides; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Knockdown Techniques; Glutaminase; Glutamine; Humans; Indoles; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Purines; Real-Time Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Thiadiazoles; TOR Serine-Threonine Kinases	2016
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells. Cancer cell, 2016, Apr-11, Volume: 29, Issue:4 Topics: Adenosine Triphosphate; Animals; Carcinoma; Cell Line, Tumor; Citric Acid Cycle; Combined Modality Therapy; Cytokines; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Everolimus; Female; Glucose-6-Phosphate Isomerase; Glutaminase; Glutamine; Glycolysis; Hep G2 Cells; Humans; Mechanistic Target of Rapamycin Complex 1; Metabolomics; Mice; Mice, Nude; Molecular Targeted Therapy; Multiprotein Complexes; Neoplasm Proteins; Neoplasms; Ovarian Neoplasms; Pentose Phosphate Pathway; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; RNA, Small Interfering; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays	2016
Altered glutamine metabolism in platinum resistant ovarian cancer. Oncotarget, 2016, Jul-05, Volume: 7, Issue:27 Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Glutaminase; Glutamine; Humans; Metabolic Networks and Pathways; Ovarian Neoplasms; Proteome	2016
Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models. BMC cancer, 2016, 10-26, Volume: 16, Issue:1 Topics: Animals; Autophagy; Cell Line, Tumor; Disease Models, Animal; Female; Glucose; Glutamates; Glutamine; Glycolysis; Heterografts; Humans; Membrane Potential, Mitochondrial; Metabolic Networks and Pathways; Mice; Mitochondria; Ovarian Neoplasms; Oxidative Stress; Positron Emission Tomography Computed Tomography; rho GTP-Binding Proteins	2016
Amplification of USP13 drives ovarian cancer metabolism. Nature communications, 2016, 11-28, Volume: 7 Topics: Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Disease Progression; Endopeptidases; Female; Gene Amplification; Gene Knockdown Techniques; Genome, Human; Glutamine; HEK293 Cells; Humans; Lipids; Mitochondria; Neoplasm Metastasis; Ovarian Neoplasms; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins c-akt; Substrate Specificity; Ubiquitin-Specific Proteases; Ubiquitination	2016
Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties. Oncology reports, 2017, Volume: 37, Issue:3 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Blotting, Western; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glutamine; Humans; Middle Aged; Neoplasm Staging; Neoplastic Stem Cells; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Signal Transduction; Tumor Cells, Cultured; Young Adult	2017
Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro. International journal of oncology, 2017, Volume: 50, Issue:4 Topics: Adenocarcinoma, Clear Cell; Aminooxyacetic Acid; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Enzyme Inhibitors; Female; Focal Adhesion Kinase 1; Glutamine; Humans; Ovarian Neoplasms; Phosphorylation; Quinolones; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Spheroids, Cellular; Sulfones; TOR Serine-Threonine Kinases; Transaminases	2017
Acivicin with glutaminase regulates proliferation and invasion of human MCF-7 and OAW-42 cells--an in vitro study. Indian journal of experimental biology, 2008, Volume: 46, Issue:1 Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Collagen; Drug Combinations; Female; Glutaminase; Glutamine; Humans; In Vitro Techniques; Isoxazoles; Laminin; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Ovarian Neoplasms; Proteoglycans; Tetrazolium Salts; Thiazoles; Vascular Endothelial Growth Factor A	2008
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs. British journal of cancer, 2003, May-19, Volume: 88, Issue:10 Topics: Adenocarcinoma; Endothelial Growth Factors; Endothelium; Female; gamma-Glutamyl Hydrolase; Glutamates; Glutamine; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Mutagenesis, Site-Directed; Neovascularization, Pathologic; Nitrogen Mustard Compounds; Ovarian Neoplasms; Plasmids; Point Mutation; Prodrugs; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors	2003
Modulation of tumor induced angiogenesis in Ehrlich ascites tumor. Journal of experimental & clinical cancer research : CR, 2004, Volume: 23, Issue:4 Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Diazooxonorleucine; Dose-Response Relationship, Drug; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Mice; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Time Factors; Vascular Endothelial Growth Factor A	2004
Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors. Oncogene, 1997, Apr-24, Volume: 14, Issue:16 Topics: Amino Acid Sequence; Animals; Cell Cycle Proteins; Cell Line, Transformed; Chromosome Deletion; Chromosome Mapping; Chromosomes, Human, Pair 6; Cloning, Molecular; DNA-Binding Proteins; DNA, Complementary; Epithelium; Female; Genes, Tumor Suppressor; Glutamine; Humans; In Situ Hybridization, Fluorescence; Molecular Sequence Data; Ovarian Neoplasms; Ovary; Polymerase Chain Reaction; Proline; Rats; Sequence Homology, Amino Acid; Transcription Factors; Tumor Suppressor Proteins; Zinc Fingers	1997
[Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries]. Orvosi hetilap, 2000, May-21, Volume: 141, Issue:21 Topics: Adult; Age Factors; Aged; beta Catenin; Cadherins; Carcinoma; Cytoskeletal Proteins; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Isoleucine; Lysine; Middle Aged; Mutation; Neoplasm Staging; Ovarian Neoplasms; Polymerase Chain Reaction; Serine; Trans-Activators	2000